Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study

European Heart Journal

Volumn 37, Issue 12, 2016, Pages 988-995

  Seravalle, Gino ^a   Piperno, Alberto ^b,c   Mariani, Raffaella ^c   Pelloni, Irene ^c   Facchetti, Rita ^b   Dell'oro, Raffaella ^b   Cuspidi, Cesare ^a   Mancia, Giuseppe ^a   Grassi, Guido ^b,d  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

Cardiovascular risk; Haemochromatosis; Iron depletion; Iron overload; Serum ferritin; Sympathetic nervous system

Indexed keywords

FERRITIN; HEPCIDIN; NORADRENALIN; TRANSFERRIN; IRON CHELATING AGENT;

ADULT; ARTICLE; BLOOD PRESSURE VARIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FERRITIN BLOOD LEVEL; HEART RATE VARIABILITY; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; IRON DEPLETION; IRON DEPLETION THERAPY; IRON OVERLOAD; MALE; MIDDLE AGED; MUSCLE SYMPATHETIC NERVE ACTIVITY; NORADRENALIN BLOOD LEVEL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; ADRENAL CORTEX HYPERFUNCTION; ADRENERGIC SYSTEM; BLOOD PRESSURE; CASE CONTROL STUDY; DRUG EFFECTS; GENETICS; HEART RATE; INNERVATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ADRENOCORTICAL HYPERFUNCTION; ADULT; BAROREFLEX; BLOOD PRESSURE; CASE-CONTROL STUDIES; FERRITINS; HEART RATE; HEMOCHROMATOSIS; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; MUSCLE, SKELETAL; SYMPATHETIC NERVOUS SYSTEM; TRANSFERRIN;

EID: 84964632240     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv696     Document Type: Article

References (35)

1. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-811
2. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 330: 1119-1124
3. Gillum RF, Sempos CT, Makuc DM, Looker AC, Chien CY, Ingram D. Serum transferrin, stroke incidence and mortality in women and men: the NHANES I epidemiologic follow-up study. Am J Epidemiol 1996; 144: 59-68
4. Franco RF, Zago MA, Trip MD, Ten Cate HEA, Prins MH, Kastelein JJ, Reitsma PH. Prevalence of hereditary hemochromatosis in premature atherosclerotic vascular disease. Br J Haematol 1998; 102: 1172-1175
5. Fox CJ, Cullen DJ, Knuiman MW, Cumpston GN, Divitini ML, Rossi E, Gochee PA, Powell LW, Olynyk JK. Effects of body iron stores and hemochromatosis genotypes on coronary heart disease outcomes in the Busselton Heath Study. J Cardiovasc Risk 2002; 9: 287-293
6. Ellervik C, Tybjaerg-Hansen A, Grande P, Appleyard M, Nordestgaard BG. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study. Circulation 2005; 112: 185-193
7. Gaenzer H, Marschang P, Sturm W, Neumayr G, Vogel W, Patsch J, Weiss G. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 2002; 40: 2189-2194
8. Shizukuda Y, Bolan CD, Nguyen TT, Botello G, Tripodi DJ, Yau YY, Waclawiw MA, Leitman SF, Rosing DR. Oxidative stress in asymptomatic subjects with hereditary hemochromatosis. Am J Hematol 2007; 82: 249-250
9. Failla M, Giannattasio c, Piperno A, Vergani A, Grappiolo A, Gentile G, Meles E, Mancia G. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 2000; 32: 569-573
10. Moller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J 2013; 34: 2804-2811
11. Lipinski B, Pretorius E. Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron. Hepatology 2012; 17: 241-247
12. Youdim MB, Ben-Shachar D, Ashkenazi R, Yehuda S. Brain iron and dopamine receptor function. Adv Biochem Psychopharmacol 1983; 37: 309-321
13. Grassi Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res 2015; 116: 976-990
14. Cardoso LM, Fernandes LG, Alves AM, Pedrosa ML, Silva ME, Colombari E, Moraes MF, Chianca JDA. Cardiopulmonary reflex is attenuated in iron overload conscious rats. Nutr Neurosci 2007; 10: 121-128
15. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823
16. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 2001; 22: 1136-1143
17. Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology 2001; 57: 833-838
18. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS, Cateliotti A. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-1359
19. Pietrangelo A. Hereditary hemochromatosis - A new look to an old disease. N Engl J Med 2004; 35: 2383-2397
20. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Disease (ASLD). Hepatology 2011; 54: 328-343
21. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92: 3206-3211
22. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell?Oro R, Mancia G. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension. 2011; 57: 846-851
23. Hjemdahl P, Daleskog M, Kahan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 1979; 25: 131-138
24. Gandon Y, OliviéD, Guyader D, AubéC, Oberti F, Sebille V, Deugnier Y. Noninvasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-362
25. Bansal SS, Abbate V, Bomford A, Haket JM, macdougall IC, Thein SL, Hider RC. Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear iron trap mass spectrometer. Rapid Commun Mass Spectrom 2010; 15: 1251-1259
26. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, Phillip J, Portman BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699
27. Le Lan C, Loréal O, Cohen T, Ropert M, Glickstein H, LainéF, Pouchard M, Deugnier Y, Le Treut A, Breuer W, Cabantchik ZI, Brissot P. Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood 2005; 105: 4527-4531
28. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman N. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee onQuantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367
29. Park SH, Shub C, Nobrega TP, Bailey KR, Seward JB. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography. J Am Soc Echocardiogr. 1996; 9: 119-128
30. Sassi R, Cerutti S, Lombardi F, Malik M, Huikuri HV, Peng CK, Schmidt G, Yamamoto Y. Advances in heart rate variability signal analysis: joint position statement by e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Rhythm Society. Europace 2015; 17: 1341-1353
31. Baselli G, Cerutti S, Civardi S, Liberati D, Lomardi F, Malliani A, Pagani M. Spectral and cross-spectral analysis of heart rate and blood pressure variability signals. Comput Biomed Res 1986; 19: 520-534
32. Kienbaum P, Karlssonn T, Sverrisdottir YB, Elam M, Wallin BG. Two sites for modulation of human sympathetic activity by arterial baroreceptors? J Physiol 2001; 531(Pt 3): 861-869
33. Grassi G, Seravalle G, Brambilla G, Trabattoni D, Cuspidi C, Corso R, Pieruzzi F, Genovesi S, Stella A, Facchetti R, Spaziani D, Bartorelli A, Mancia G. Blood pressure responses to renal denervation precede an are independent of the sympathetic and baroreflex effects. Hypertension 2015; 65: 1209-1216
34. Brissot P, Ropert M, Le Lan C, Lorèal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 2012; 1820: 403-410
35. Lepori M, Sartori C, Trueb L, Owlya R, Nicod P, Scherrer U. Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of N(G)-monomethyl-L-arginine into humans are dose dependent. J Hypertens 1998; 16: 519-523